Skip to content

The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality

The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality as Compared to a Melatonin Control: A Randomized, Double-Blinded, Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06894108
Enrollment
89
Registered
2025-03-25
Start date
2024-10-01
Completion date
2025-04-30
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Brief summary

The purpose of this study is to evaluate the efficacy and superiority of a botanical based sleep product on sleep quality as compared to melatonin, among healthy female participants.

Interventions

DIETARY_SUPPLEMENTProprietary Blend of Botanical Extracts

Participants consumed 2.4ml of the supplement each night before bed.

DIETARY_SUPPLEMENTMelatonin

Participants consumed 1mg melatonin each night before bed.

Sponsors

Nutraceuticals Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Provision of signed and dated informed consent form Stated willingness and demonstrated ability to comply with all study procedures, as well as availability for the duration of the study Self reported poor sleep quality Biological sex of woman; gender identification of female Aged 35 to 55, inclusive Good general health as evidenced by medical history and screening For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional month after the end of the study Has an apple watch or similar device Agreement to adhere to Lifestyle Considerations throughout study duration

Exclusion criteria

Pregnancy, trying to conceive, or breastfeeding Currently smokes or vapes (i.e., tobacco, flavored items, marijuana, etc.) or has in the past year Has received medical diagnosis or treatment for any sleep disorder in the past year Has ever received a medical diagnosis of sleep apnea or narcolepsy Works a night shift, is on-call or performs any job requiring or potentially requiring work related responsibilities after 8pm Consumes \> 8 alcoholic beverages in an average week Is a primary caretaker for a child younger than 18 months of age Consumes any sleep aid, medication, diet, or supplement intended to improve sleep in any way Known allergic reactions to any components of the intervention Positive COVID-19 test within 30 days of the study period Recent dramatic weight changes (10% change in body weight in the last 6 months) Introducing a new investigational drug or other intervention within 60 days before the start of the study

Design outcomes

Primary

MeasureTime frameDescription
NRI Sleep ScaleFrom baseline to the end of the 28 day intervention.The NRI Sleep Scale is a validated measure of sleep health. It has 6 domains, each measured on a Likert scale, with higher scores indicating greater sleep disturbances.

Secondary

MeasureTime frameDescription
Wearable TechnologyFrom baseline to the end of the 28 day intervention.Sleep data sourced from the participant's Apple Watch (time in bed, time spent per phase (awake, REM, core, and deep).
NRI Energy ScaleFrom baseline to the end of the 28 day intervention.Description: The NRI Energy Scale is a validated measure of fatigue. It has 7 domains, each measured on a Likert scale, with higher scores indicating greater fatigue.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026